Researchers at the University of California, Irvine, have developed a groundbreaking therapy for Alzheimer’s disease by using ...

Alzheimer’s early detection is now more accessible with blood tests, as survey data shows nearly 80% of Americans want to ...

Generally, Americans are optimistic about new treatments to slow or prevent Alzheimer’s. More than 4 out of 5 (81%) believe ...

SIGN UP TO CONTINUEPrint Subscriber? Sign Up for Full Access!Please sign up for as low as 36 cents per day to continue ...

In the past, most studies focused on two main ideas about what triggers Alzheimer’s. One idea is that a sticky protein called ...

An increase in physical activity between the ages of 45 and 65 could help prevent Alzheimer's disease, while inactivity may ...

A report from the Alzheimer’s Association says new treatments and blood tests could change how doctors detect and treat the ...

Americans are eager for early diagnosis and treatment and would accept some risk with taking medication to slow the ...

Rates of Alzheimer’s Disease is on the rise at a time when the nation is facing a shortage of caregivers. According to the ...

Xanamem is an investigational product and is not approved for use outside of a clinical trial by the FDA or by any global regulatory authority. Xanamem ® is a trademark of Actinogen Medical.

Some risk factors and blood biomarkers related to Alzheimer's disease and cognitive impairment can be detected as early as ...

A survey of 1700 Americans 45 and older found that 79% would want to know if they were in the early stages of Alzheimer's.